Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Symptom C0018799|heart disease
Sentences 23
PubMedID- 21139493 Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome.
PubMedID- 19935427 The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.
PubMedID- 19969373 Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the heart and soul study.
PubMedID- 24174878 After an additional follow-up period of 4.9 years, coronary artery calcium progression was able to predict coronary heart disease events in patients with metabolic syndrome and without type 2 diabetes, as well as in those with type 2 diabetes.
PubMedID- 20940070 Objective: we examined the risk of cardiovascular disease, stroke, ischaemic heart disease, and diabetes with the metabolic syndrome according to the new harmonised definition and its components using a national longitudinal data set from an asian population.
PubMedID- 21151616 Unlike class i and iia hdacs, class iii hdacs play an important role in regulating oxidative stress in heart diseases with metabolic syndromes.
PubMedID- 22906266 Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status.
PubMedID- 22355990 Conclusion: frequency of metabolic syndrome with ischaemic heart disease was high in females as compared to males.
PubMedID- 26274823 The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study.
PubMedID- 23091851 Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism.
PubMedID- 24793349 Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians.
PubMedID- 21636030 We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome.
PubMedID- 22780328 Introduction: excessive abdominal obesity along with other risk factors results in the metabolic syndrome, which can lead to heart disease, type-2 diabetes, and death.
PubMedID- 21153653 Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics.
PubMedID- 26401840 Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study.
PubMedID- 22323895 A widely held view is that large hdl2 particles are atheroprotective.27 the role of hdl3 particles in preventing atherogenesis on the other hand is less clear.27,28 some studies have reported that hdl3 is significantly associated with coronary heart disease, particularly in patients with metabolic syndrome because small hdl particles coincide with low hdl cholesterol levels and can be functionally compromised in patients with metabolic syndrome.4,16 other studies associate the small hdl3 particle with atheroprotective functions, including an ability to mature into larger hdl2 and promote reverse cholesterol transport, and to antagonize and inhibit inflammation and oxidation within blood vessel walls.29–31 discordance in these data may reflect the complex relationships between hdl subclasses, methods of fractionation, physiological versus pathological conditions (such as metabolic diseases or presence of coronary artery disease), or treatment effects with different lipid-modifying drugs.
PubMedID- 21186101 metabolic syndrome was strongly associated with coronary heart disease (or = 4.03; 95% ci: 2.98, 5.45) and the risk seemed to be fully explained by metabolic syndrome components (or = 0.84, p = 0.54 after adjustment).
PubMedID- 22323866 Visceral fat is independently related to morbidity and mortality of the coronary heart disease and associated with metabolic syndrome, diabetes, and cardiovascular disease.
PubMedID- 22548293 metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat).
PubMedID- 23479983 Quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis.
PubMedID- 23251156 The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin .
PubMedID- 22131755 furthermore, insulin-resistant patients, with and without type 2 diabetes, are at an increased risk for developing metabolic syndrome, a major cause of heart disease, hypertension and dyslipidemia.
PubMedID- 23819342 Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome.

Page: 1